Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03556384
Title Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Adam Burgoyne, MD, PhD
Indications

gastrointestinal stromal tumor

Therapies

Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.